Healthcare
-
Harris seeks to lower drug costs for Wisconsinites, building on recent progress
Harris wants to expand the $35 monthly cap on insulin costs and a $2,000 annual cap on out-of-pocket drug costs so that they apply to all Americans, not just seniors on Medicare.
-
Everything you need to know about the new flu and COVID vaccines
When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here’s what you need to know.
-
3 ways Medicaid expansion would help Wisconsin families
Expanding Medicaid in Wisconsin would allow tens of thousands of people to gain health care coverage, and would help alleviate hospital closures as well as address staffing shortages.
-
Who’s helping and who’s hurting health care access in Wisconsin right now
It’s been half a year since Wisconsin’s Democratic Gov. Tony Evers approved a bill that would help people get the health care they need in western Wisconsin.
-
Rural Wisconsin hospital expands obstetrics department thanks to government funding
As some surrounding birth centers are shuttering their maternity departments, a rural western Wisconsin hospital in a town of about 5,000 people is growing its women’s health and labor & delivery services.
-
This Rusk County small business owner is saving big on health care premiums – and her employees benefit, too
Record Number of Wisconsinites have lower and better health care benefits, thanks to Biden-Harris legislation
-
Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
-
For many Wisconsin families, Harris’s plans to address prescription drug costs could be life changing.
Penni Klein used to have to ration the insulin she needs to control her diabetes. But no longer – not since her medication bills dropped from $685 to $70 a month, thanks to an act of Congress, led by the How the Biden-Harris Administration.
-
Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
-
Opinion: The hidden toll of medical debt on housing and employment in Wisconsin
Medical debt’s unfair toll on housing and employment, and the need for reform.
